Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China flag China · Delayed Price · Currency is CNY
22.20
-0.29 (-1.29%)
Nov 17, 2026, 3:00 PM CST

SHA:603392 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,5192,4352,3883,8195,1931,416
Short-Term Investments
2681,168480--200
Trading Asset Securities
1,4031,4472,5102,0552,00940.39
Cash & Short-Term Investments
4,1905,0505,3785,8747,2011,656
Cash Growth
-18.29%-6.10%-8.44%-18.43%334.83%103.56%
Accounts Receivable
1,5541,6382,0642,9993,9602,277
Other Receivables
27.6397.6435.9648.715.1512.45
Receivables
1,5811,7382,1043,0533,9702,292
Inventory
749.82702.08863.19905.48869.14593.17
Other Current Assets
116.2936.5729.44469.42139.4105.2
Total Current Assets
6,6387,5268,37510,30212,1804,647
Property, Plant & Equipment
3,3463,5183,5382,6412,2351,703
Long-Term Investments
1,7721,2921,36212.01911.361.3
Other Intangible Assets
760.48797.38512.46508.28292.5289.92
Long-Term Deferred Tax Assets
363.26338.18243.33157.9566.0168.97
Long-Term Deferred Charges
392.15292.39363.85214.29172.3727.18
Other Long-Term Assets
289.12280.67294.671,879372.3249.09
Total Assets
13,56014,04414,68915,71516,2307,046

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
320.34143.61137.94234.28275.47154.08
Accrued Expenses
182.36641.71915.891,6532,5721,541
Short-Term Debt
126.45133.66103.6281.14140.14235.64
Current Portion of Long-Term Debt
48.9356.8565.6887.193.07-
Current Portion of Leases
-19.5238.4313.313.7313.93
Current Income Taxes Payable
15.150.438.597.4999.02146.55
Current Unearned Revenue
39.2841.0548.1570.3882.2870.3
Other Current Liabilities
792.43765.4693.76523.42299.34204.64
Total Current Liabilities
1,5251,8022,0122,6703,4852,366
Long-Term Debt
120.0998.7994.19115.36102.494.9
Long-Term Leases
47.7145.5780.9712.3618.4332.59
Long-Term Unearned Revenue
66.4464.3954.233.6541.3776.44
Long-Term Deferred Tax Liabilities
----17.15-
Other Long-Term Liabilities
-----3.8
Total Liabilities
1,7592,0112,2412,8313,6652,483

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,2641,2641,2651,268906.07607.04
Additional Paid-In Capital
3,0483,0483,1393,3123,729445.83
Retained Earnings
7,3217,5527,9508,2507,9063,413
Treasury Stock
---92.17-129.42-200.17-
Total Common Equity
11,63411,86512,26312,70112,3414,466
Minority Interest
167.3168.46185.16183.06223.6396.2
Shareholders' Equity
11,80112,03312,44812,88412,5654,562
Total Liabilities & Equity
13,56014,04414,68915,71516,2307,046

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
343.18354.39382.91309.35277.86287.06
Net Cash (Debt)
3,8474,6954,9955,5656,9231,369
Net Cash Growth
-19.10%-6.00%-10.23%-19.63%405.71%86.03%
Net Cash Per Share
2.923.653.764.425.541.11
Filing Date Shares Outstanding
1,2641,2641,2651,2681,2681,232
Total Common Shares Outstanding
1,2641,2641,2651,2681,2681,232
Working Capital
5,1135,7246,3637,6328,6952,281
Book Value Per Share
9.209.389.6910.019.733.62
Tangible Book Value
10,87311,06711,75012,19212,0494,176
Tangible Book Value Per Share
8.608.759.299.619.503.39
Buildings
-1,557779.65724.87628.89392.67
Machinery
-2,1271,7641,5101,185666.87
Construction In Progress
-571.791,469814.56720.51924.38